HomeAI · summaries
Storia in 6 fonti
Pfizer unveils additional $2.5B in planned cost savings through 2029
Pfizer will reduce its costs by $2.5 billion in another round of cutbacks which will kick in next year and run through 2029. | Pfizer will reduce its costs by $2.5 billion in another round of cutbacks which will begin next year and run through 2029. The additional cost savings swell Pfizer's program to $9.7 billion in reductions.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Pfizer expands multibillion-dollar cost-cutting plan
Hatched three years ago, the restructuring is now expected to deliver $1 billion in new cost reductions and save Pfizer another $1.5 billion by streamlining drug production.
- ·
endpoints.news
Pfizer to make $2.5B in new cost cuts
Pfizer’s yearslong cost-cutting effort is continuing apace, and it disclosed a $4.3 billion write-down tied to a Phase 3 trial miss for sigvotatug vedotin.
